BioCurex Inc. Comments on Genetic Testing and RECAF Technology

RICHMOND, British Columbia, July 9, 2007 (PRIME NEWSWIRE) -- BioCurex (OTC BB:BOCX.OB - News) is pleased to periodically educate its shareholders regarding the increasingly voluminous material in the cancer diagnostics arena. In recent publications, there has been mention of the increasing possibility of genetic testing for various disease, degenerative and cancer states. Genetic testing is a process that looks for inherited genetic alterations that may increase your risk of certain cancers. This type of testing may show whether the risk in a family is passed through their genes.

MORE ON THIS TOPIC